EE200200535A - Konjugeeritud östrogeenide ja medroksüprogesteroonatsetaadi kasutamine, farmatseutiline kompositsioon, doseerimisühik ja pakend - Google Patents

Konjugeeritud östrogeenide ja medroksüprogesteroonatsetaadi kasutamine, farmatseutiline kompositsioon, doseerimisühik ja pakend

Info

Publication number: EE200200535A
Authority: EE; Estonia
Prior art keywords: package; pharmaceutical composition; dosage unit; medroxyprogesterone acetate; conjugated estrogens
Prior art date: 2000-03-20

Application number

EEP200200535A

Other languages

English (en)

Inventor

Harrison Pickar James

Original Assignee

Wyeth

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-20

Filing date

2001-03-16

Publication date

2004-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26886279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200200535(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-03-16 Application filed by Wyeth filed Critical Wyeth

2004-04-15 Publication of EE200200535A publication Critical patent/EE200200535A/et

2009-02-16 Publication of EE05129B1 publication Critical patent/EE05129B1/et

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Psychiatry (AREA)

EEP200200535A 2000-03-20 2001-03-16 Konjugeeritud strogeenide ja medroksprogesteroonatsetaadi kasutamine, farmatseutiline kompositsioon, doseerimishik ja pakend EE05129B1 (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US19063000P	2000-03-20	2000-03-20
US26860701P	2001-02-14	2001-02-14
PCT/US2001/040302 WO2001070208A2 (en)	2000-03-20	2001-03-16	Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate

Publications (2)

Publication Number	Publication Date
EE200200535A true EE200200535A (et)	2004-04-15
EE05129B1 EE05129B1 (et)	2009-02-16

Family

ID=26886279

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200535A EE05129B1 (et)	2000-03-20	2001-03-16	Konjugeeritud strogeenide ja medroksprogesteroonatsetaadi kasutamine, farmatseutiline kompositsioon, doseerimishik ja pakend

Country Status (30)

Country	Link
US (2)	US20010034340A1 (et)
EP (1)	EP1265616B1 (et)
JP (1)	JP2003527416A (et)
KR (1)	KR100805648B1 (et)
CN (1)	CN1239160C (et)
AR (1)	AR031563A1 (et)
AT (1)	ATE326227T1 (et)
AU (2)	AU5003401A (et)
BG (1)	BG66075B1 (et)
BR (1)	BR0109334A (et)
CA (1)	CA2402983A1 (et)
CY (1)	CY1105632T1 (et)
CZ (1)	CZ20023162A3 (et)
DE (1)	DE60119703T2 (et)
DK (1)	DK1265616T3 (et)
EA (1)	EA005592B1 (et)
EE (1)	EE05129B1 (et)
ES (1)	ES2261393T3 (et)
HK (1)	HK1049449B (et)
HR (1)	HRP20020837B1 (et)
HU (1)	HUP0302093A3 (et)
IL (1)	IL151512A0 (et)
MX (1)	MXPA02009116A (et)
NO (1)	NO326886B1 (et)
NZ (1)	NZ521171A (et)
PL (1)	PL201762B1 (et)
PT (1)	PT1265616E (et)
SK (1)	SK286169B6 (et)
TW (1)	TWI271194B (et)
WO (1)	WO2001070208A2 (et)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010044431A1 (en) *	2000-03-21	2001-11-22	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6245819B1 (en)	2000-07-21	2001-06-12	Hormos Medical Oy, Ltd.	Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
SG153645A1 (en) *	2001-03-16	2009-07-29	Wyeth Corp	Hormone replacement therapy
EP1857110A3 (en) *	2001-03-16	2008-08-06	Wyeth	Hormone replacement therapy
WO2008150547A1 (en)	2007-06-04	2008-12-11	The Regents Of The University Of California	Pregnancy hormone combination for treatment of autoimmune diseases
US20130203722A1 (en)	2006-09-26	2013-08-08	Rhonda R. Voskuhl	Estriol therapy for autoimmune and neurodegenerative disease and disorders
TWI252111B (en) *	2001-12-14	2006-04-01	Solvay Pharm Gmbh	Matrix film tablet with controlled release of a natural mixture of conjugated estrogens
TW200306846A (en) *	2002-04-03	2003-12-01	Wyeth Corp	Hormone replacement therapy
TW200306196A (en) *	2002-04-03	2003-11-16	Wyeth Corp	Hormone replacement therapy
CA2481310A1 (en) *	2002-04-03	2003-10-16	Barr Laboratories, Inc.	Step-down estrogen therapy
TW200306851A (en) *	2002-04-29	2003-12-01	Wyeth Corp	Hormone replacement therapy
TW200400040A (en) *	2002-05-17	2004-01-01	Wyeth Corp	Hormone replacement therapy
DK1509215T3 (da) *	2002-06-06	2007-03-12	Hormos Medical Ltd	Behandling eller forebyggelse af urogenital atrofi og dets symptomer hos kvinder
WO2004000801A2 (en) *	2002-06-25	2003-12-31	Wyeth	Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
RU2005101635A (ru) *	2002-06-25	2005-08-10	Уайт (Us)	Применение производных тиооксиндола в терапии гормонозависимых состояний
US8349819B2 (en)	2002-10-09	2013-01-08	Dr. Reddy's Laboratories New York, Inc.	Steroid extraction process from urine sources
EP1622623A4 (en) *	2003-04-11	2009-03-18	Barr Lab Inc	METHOD FOR THE ADMINISTRATION OF ESTROGENIC AND TESTED
US20060040904A1 (en) *	2004-08-17	2006-02-23	Ahmed Salah U	Vaginal cream compositions, kits thereof and methods of using thereof
WO2007076144A2 (en)	2005-12-27	2007-07-05	Duramed Pharmaceuticals, Inc.	Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
MX2008012880A (es) *	2006-04-05	2008-10-13	Wyeth Corp	Metodos para la prevencion y tratamiento de condiciones que surgen de deficiencia de estrogeno local.
AR064014A1 (es) *	2006-11-29	2009-03-04	Wyeth Corp	Tabletas bi-capa de estrogeno/moduladores selectivos de receptores de estrogeno (serm) y estrogeno/progestina
US7504530B2 (en) *	2007-02-14	2009-03-17	Hormos Medical Ltd.	Methods for the preparation of fispemifene from ospemifene
AU2008214530B2 (en) *	2007-02-14	2012-04-26	Hormos Medical Ltd	Method for the preparation of therapeutically valuable triphenylbutene derivatives
KR100989093B1 (ko)	2008-01-18	2010-10-25	한화제약주식회사	생강나무 가지의 추출물을 포함하는 심혈관계 질환의 예방 및 치료용 조성물
US9734496B2 (en)	2009-05-29	2017-08-15	Paypal, Inc.	Trusted remote attestation agent (TRAA)
BR112012019725A2 (pt) *	2010-02-08	2020-11-10	Tao Tom Du	usos de uma composição farmacêutica e uso de pelo menos um progestogênio
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
ES2885523T3 (es)	2011-11-23	2021-12-14	Therapeuticsmd Inc	Formulaciones y terapias de reposición hormonal de combinación naturales
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
JP6174156B2 (ja)	2012-10-19	2017-08-02	フェルミオンオサケユキチュア	オスペミフェンの製造方法
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
WO2015089489A1 (en) *	2013-12-13	2015-06-18	Requis Pharmaceuticals Inc.	Antihistamines in combination with a range of substance for improved health
EP3137087B1 (en)	2014-04-28	2023-09-06	The Regents of the University of California	Estrogen combination for treatment of multiple sclerosis
ES2959603T3 (es)	2014-04-28	2024-02-27	Univ California	Envase farmacéutico para terapia con estriol para el tratamiento de la esclerosis múltiple
AR100562A1 (es)	2014-05-22	2016-10-12	Therapeuticsmd Inc	Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
EP3188735A4 (en)	2014-09-02	2018-01-24	The Regents of the University of California	Estrogen therapy for brain gray matter atrophy and associated disability
ES2957543T3 (es)	2014-09-29	2024-01-22	Univ California	Composiciones y métodos para mantener la función cognitiva
EP3277285B1 (en)	2015-03-30	2024-07-17	The Regents of the University of California	Estriol for reducing cortical gray matter atrophy
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
CA3020153A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
WO2017173044A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd Inc.	Steroid hormone compositions in medium chain oils
US20210386757A1 (en) *	2018-10-17	2021-12-16	Sarah S. Stadler	Methods of Treating Menopausal Symptoms Using Low Dose Progesterone
US11633405B2 (en)	2020-02-07	2023-04-25	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4826831A (en) *	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU582540B2 (en) *	1983-08-05	1989-04-06	Pre Jay Holdings Ltd.	A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
ATE209919T1 (de) *	1987-09-24	2001-12-15	Jencap Res Ltd	Oestrogen und progestin enthaltende verhütungspackungen
NL9301562A (nl) *	1993-09-09	1995-04-03	Saturnus Ag	Preparaat voor substitutietherapie.
US5554601A (en) *	1993-11-05	1996-09-10	University Of Florida	Methods for neuroprotection
US5547948A (en) *	1995-01-17	1996-08-20	American Home Products Corporation	Controlled release of steroids from sugar coatings
US5759577A (en) *	1995-01-17	1998-06-02	American Home Products Corporation	Controlled release of steroids from sugar coatings

2001
- 2001-03-15 US US09/808,878 patent/US20010034340A1/en not_active Abandoned
- 2001-03-16 EP EP01923331A patent/EP1265616B1/en not_active Expired - Lifetime
- 2001-03-16 HU HU0302093A patent/HUP0302093A3/hu unknown
- 2001-03-16 EA EA200201000A patent/EA005592B1/ru not_active IP Right Cessation
- 2001-03-16 SK SK1348-2002A patent/SK286169B6/sk not_active IP Right Cessation
- 2001-03-16 ES ES01923331T patent/ES2261393T3/es not_active Expired - Lifetime
- 2001-03-16 MX MXPA02009116A patent/MXPA02009116A/es active IP Right Grant
- 2001-03-16 PT PT01923331T patent/PT1265616E/pt unknown
- 2001-03-16 IL IL15151201A patent/IL151512A0/xx not_active IP Right Cessation
- 2001-03-16 DE DE60119703T patent/DE60119703T2/de not_active Expired - Lifetime
- 2001-03-16 JP JP2001568406A patent/JP2003527416A/ja active Pending
- 2001-03-16 NZ NZ521171A patent/NZ521171A/en not_active IP Right Cessation
- 2001-03-16 CA CA002402983A patent/CA2402983A1/en not_active Abandoned
- 2001-03-16 HK HK03101651.5A patent/HK1049449B/en not_active IP Right Cessation
- 2001-03-16 AU AU5003401A patent/AU5003401A/xx active Pending
- 2001-03-16 CZ CZ20023162A patent/CZ20023162A3/cs unknown
- 2001-03-16 WO PCT/US2001/040302 patent/WO2001070208A2/en not_active Ceased
- 2001-03-16 KR KR1020027012420A patent/KR100805648B1/ko not_active Expired - Fee Related
- 2001-03-16 HR HR20020837A patent/HRP20020837B1/xx not_active IP Right Cessation
- 2001-03-16 DK DK01923331T patent/DK1265616T3/da active
- 2001-03-16 AU AU2001250034A patent/AU2001250034B2/en not_active Ceased
- 2001-03-16 BR BR0109334-7A patent/BR0109334A/pt not_active Application Discontinuation
- 2001-03-16 EE EEP200200535A patent/EE05129B1/et not_active IP Right Cessation
- 2001-03-16 PL PL363157A patent/PL201762B1/pl not_active IP Right Cessation
- 2001-03-16 AT AT01923331T patent/ATE326227T1/de active
- 2001-03-16 CN CNB018068235A patent/CN1239160C/zh not_active Expired - Fee Related
- 2001-03-19 TW TW090106349A patent/TWI271194B/zh not_active IP Right Cessation
- 2001-03-19 AR ARP010101273A patent/AR031563A1/es unknown
2002
- 2002-09-12 BG BG107095A patent/BG66075B1/xx unknown
- 2002-09-19 NO NO20024478A patent/NO326886B1/no not_active IP Right Cessation
2006
- 2006-07-03 CY CY20061100910T patent/CY1105632T1/el unknown
2007
- 2007-11-06 US US11/979,633 patent/US20090005351A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1239160C (zh)	2006-02-01
PT1265616E (pt)	2006-08-31
ATE326227T1 (de)	2006-06-15
CY1105632T1 (el)	2010-12-22
HK1049449A1 (en)	2003-05-16
PL201762B1 (pl)	2009-05-29
SK13482002A3 (sk)	2003-02-04
BG107095A (bg)	2003-05-30
CN1418102A (zh)	2003-05-14
BG66075B1 (en)	2011-02-28
CA2402983A1 (en)	2001-09-27
PL363157A1 (en)	2004-11-15
BR0109334A (pt)	2002-12-24
HK1049449B (en)	2006-07-28
SK286169B6 (sk)	2008-04-07
WO2001070208A3 (en)	2002-04-25
US20090005351A1 (en)	2009-01-01
KR100805648B1 (ko)	2008-02-26
KR20020084230A (ko)	2002-11-04
NO20024478L (no)	2002-09-19
MXPA02009116A (es)	2003-03-12
DE60119703D1 (de)	2006-06-22
AU5003401A (en)	2001-10-03
CZ20023162A3 (cs)	2003-03-12
HUP0302093A3 (en)	2010-03-29
DK1265616T3 (da)	2006-06-12
WO2001070208A2 (en)	2001-09-27
HUP0302093A2 (hu)	2003-10-28
IL151512A0 (en)	2003-04-10
AU2001250034B2 (en)	2005-03-24
DE60119703T2 (de)	2006-10-19
ES2261393T3 (es)	2006-11-16
HRP20020837A2 (en)	2004-02-29
NO326886B1 (no)	2009-03-16
NO20024478D0 (no)	2002-09-19
AR031563A1 (es)	2003-09-24
EP1265616B1 (en)	2006-05-17
EA005592B1 (ru)	2005-04-28
EA200201000A1 (ru)	2003-02-27
EE05129B1 (et)	2009-02-16
HRP20020837B1 (hr)	2007-08-31
JP2003527416A (ja)	2003-09-16
NZ521171A (en)	2004-09-24
US20010034340A1 (en)	2001-10-25
TWI271194B (en)	2007-01-21
EP1265616A2 (en)	2002-12-18

Publication	Publication Date	Title
EE200200535A (et)	2004-04-15	Konjugeeritud östrogeenide ja medroksüprogesteroonatsetaadi kasutamine, farmatseutiline kompositsioon, doseerimisühik ja pakend
EE200300207A (et)	2003-08-15	Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
EE05081B1 (et)	2008-10-15	Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, 3-aminoasetidiini derivaadid ja nende valmistamise meetodid
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
ATE453391T1 (de)	2010-01-15	Östrogene mittel enthaltende arzneizusammensetzungen
EE200300240A (et)	2003-08-15	Arüülitud furaan- ja tiofeenkarboksamiid, seda sisaldav ravimpreparaat ning ühendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks
EE04965B1 (et)	2008-02-15	Imidasoimidasoolid ja triasoolid kui p?letikuvastased hendid, nende kasutamine ravimite valmistamiseks ning farmatseutiline kompositsioon
EE200300145A (et)	2003-06-16	Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
NO20020464L (no)	2002-03-20	Flerkomponents farmasöytisk doseringsform
EE200100391A (et)	2002-10-15	Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon
EE05475B1 (et)	2011-10-17	Superantigeeni sisaldav konjugaat, konjugaadi kasutamine ja konjugaati sisaldav farmatseutiline kompositsioon
EE04997B1 (et)	2008-04-15	Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
EE200200075A (et)	2003-04-15	Peroraalselt ja paikselt manustatavad farmatseutilised kompositsioonid
AR028023A1 (es)	2003-04-23	Una composicion farmaceutica para el tratamiento de la hiperlipidemia y el uso de dicha composicion para la preparacion de medicamentos
NO20021898L (no)	2002-04-22	Farmasoytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa
DE60024476D1 (de)	2006-01-05	Pedikulizide und veterinärmedizinische zusammensetzungen
BR0012184B1 (pt)	2013-09-24	compostos derivados de indol, formulação farmacêutica, e, composição e uso dos compostos na fabricação de medicamentos
EE200200551A (et)	2004-04-15	Oligosahhariide sisaldav farmatseutiline kompositsioon, oligosahhariidid, nende valmistamine ja raviotstarbeline kasutamine
EE200900049A (et)	2009-10-15	Etinlstradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
EE200200480A (et)	2004-02-16	Memnopeptiidühend, selle valmistamine ja raviotstarbeline kasutamine ning seda sisaldav farmatseutiline kompositsioon
DE60139306D1 (de)	2009-09-03	N-deacetylthiocolchin-derivate und diese enthaltende arzneimittel
EE200300436A (et)	2003-12-15	Imidasolidiini derivaadid, nende valmistamine ja kasutamine põletikuvastaste toimeainetena ning neid sisaldav ravimpreparaat
ATE279927T1 (de)	2004-11-15	Pharmazeutische zusammensetzungen enthaltend tobramycin und xanthangummi
EE05262B1 (et)	2010-02-15	Leptiini v?i selle homoloogi v?i derivaadi kasutamine, farmatseutiline kompositsioon ja segu
IT1318654B1 (it)	2003-08-27	Composizioni farmaceutiche comprendenti agenti antiinfiammatori e lorousi.

Legal Events

Date	Code	Title	Description
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2012-12-17	MM4A	Lapsed by not paying the annual fees	Effective date: 20120316